Partner with Us To Realize the Vocxi Vision

Help Bring MyBreathPrint to Patients Worldwide

spacer

Vocxi Health’s MyBreathPrint® system is the fastest, most accessible, highly accurate breath diagnostic system available. By becoming a contributing partner to Vocxi Health, you’re empowering a detection and diagnosis platform as noninvasive and simple to use as one minute of breathing with broad applications for emergency medicine, detecting cancer, infectious disease and more. This disruptive technology will revolutionize how diseases, ailments and other health issues are identified and treated, dramatically improving healthcare access, patient survivability and healthcare system costs.

Issued US and International Patents
0 +
Patents Filed and Pending
0 +
Clinical Studies
0

Vocxi Health’s Mission is to create the most approachable, accessible and accurate breath diagnostic.

spacer

The Vocxi Difference

Changing healthcare by transforming the patient journey

line right in

What if you could help save millions of lives, one loved one at a time, by contributing to early disease detection? Vocxi Health’s vision created the truly elegant, innovative MyBreathPrint system…a decade in the making. 

  • The MyBreathPrint Point of Care
  • Vocxi About Strategic Partners icons Blue revArtboard 21

    No Lab

    Data goes from the device to the cloud to the clinician. No fluids to collect or to mix.

    Vocxi About Strategic Partners icons Blue revArtboard 29

    No ionization

    There is no processing of breath, no data loss and it works at normal breath humidity levels.

    Vocxi Icons White w Light Blue Circle

    size

    10- to 100-times smaller than other diagnostic systems – about the size of a deck of cards.

    Vocxi About Strategic Partners icons light blueArtboard 30

    lower cost of care

    With its small size, streamlined process, it has the potential to transform the cost of care for patients, providers and payers.

    Vocxi About Strategic Partners icons Blue revArtboard 31

    mobile

    With its handheld ease and connectivity, it can be used in any clinical setting or from home.

    Vocxi About Strategic Partners icons Blue revArtboard 32

    Scalable manufacturing

    Leverages microelectronic technology for efficient, expansible manufacturing.

  • The MyBreathPrint System
  • Vocxi About Strategic Partners icons light blueArtboard 33

    Accelerated Development

    Designed to measure a full spectrum of disease-related VOCs. No hardware changes needed to train on other ailments — train, validate, test.

    Vocxi About Strategic Partners icons light blueArtboard 34

    Orthogonal Vs Liquid Biopsy

    MyBreathPrint measures VOCs, an orthogonal dataset, and instantly translates a breath sample to data without weeks of delay.

    Vocxi About Strategic Partners icons light blueArtboard 26

    Aligned for Early Detection

    VOCs are a by-product of metabolic/physiological activity in the body and well suited for detecting even early stages of disease with high accuracy.

    Vocxi About Strategic Partners icons light blueArtboard 35

    Connected anywhere

    With its machine learning approach, MyBreathPrint enables epidemiological observations across populations: locally, nationally and globally.

    Vocxi About Strategic Partners icons Blue revArtboard 36

    Smarter Over Time

    MyBreathPrint will generate big data machine-learning value creation — enabling opportunities such as virtual clinical trials.

    Vocxi About Strategic Partners icons Blue revArtboard 23

    Immediate Results

    Data is captured in real time with the analysis process taking place in seconds from breathing to results. 20,000x faster than other diagnostics that can take weeks!

    Vocxi About Strategic Partners icons Blue revArtboard 37

    Platform

    With one hardware design, it’s quickly scalable and translatable and, with its machine learning platform, quickly customizable for multiple conditions/uses.  

Vocxi About Strategic Partners icons Blue revArtboard 21

No Lab

Data goes from the device to the cloud to the clinician. No fluids to collect or to mix.

Vocxi About Strategic Partners icons Blue revArtboard 29

No ionization

There is no processing of breath, no data loss and it works at normal breath humidity levels.

Vocxi Icons White w Light Blue Circle

size

10- to 100-times smaller than other diagnostic systems – about the size of a deck of cards.

Vocxi About Strategic Partners icons light blueArtboard 30

lower cost of care

With its small size, streamlined process, it has the potential to transform the cost of care for patients, providers and payers.

Vocxi About Strategic Partners icons Blue revArtboard 31

mobile

With its handheld ease and connectivity, it can be used in any clinical setting or from home.

Vocxi About Strategic Partners icons Blue revArtboard 32

Scalable manufacturing

Leverages microelectronic technology for efficient, expansible manufacturing.

Vocxi About Strategic Partners icons light blueArtboard 33

Accelerated Development

Designed to measure a full spectrum of disease-related VOCs. No hardware changes needed to train on other ailments — train, validate, test.

Vocxi About Strategic Partners icons light blueArtboard 34

Orthogonal Vs Liquid Biopsy

MyBreathPrint measures VOCs, an orthogonal dataset, and instantly translates a breath sample to data without weeks of delay.

Vocxi About Strategic Partners icons light blueArtboard 26

Aligned for Early Detection

VOCs are a by-product of metabolic/physiological activity in the body and well suited for detecting even early stages of disease with high accuracy.

Vocxi About Strategic Partners icons light blueArtboard 35

Connected anywhere

With its machine learning approach, MyBreathPrint enables epidemiological observations across populations: locally, nationally and globally.

Vocxi About Strategic Partners icons Blue revArtboard 36

Smarter Over Time

MyBreathPrint will generate big data machine-learning value creation — enabling opportunities such as virtual clinical trials.

Vocxi About Strategic Partners icons Blue revArtboard 23

Immediate Results

Data is captured in real time with the analysis process taking place in seconds from breathing to results. 20,000x faster than other diagnostics that can take weeks!

Vocxi About Strategic Partners icons Blue revArtboard 37

Platform

With one hardware design, it’s quickly scalable and translatable and, with its machine learning platform, quickly customizable for multiple conditions/uses.  

spacer

future applications

line right in

One Platform, Many Uses

With one hardware design, MyBreathPrint is scalable and, through its machine learning platform, customizable to detect a wide variety of diseases, ailments and other health issues.

Lung Cancer and More

Each cancer has its own distinct VOC patterns and leaves distinct markers on an individual’s BreathPrint®. MyBreathPrint may be utilized with many different types of cancer in the following ways:

Emergency Medicine

Immediate non-invasive detection could be transformative in emergency medicine. MyBreathPrint has applications for preliminary assessment of patients to determine the urgency of their need in these ways.

Infectious Disease

Like cancer, there are VOC biomarkers and biomarker profiles associated with all types of infections and there are opportunities to utilize MyBreathPrint in the same ways:
spacer

Why Partner with Vocxi Health

line right in

The Power of MyBreathPrint Team and Technology

With one hardware design, MyBreathPrint is scalable and, through its machine learning platform, customizable to detect a wide variety of diseases, ailments and other health issues.

spacer

Current Vocxi Health Partners

line right in
spacer

Want to Know More?

We will never use your email for other purposes or sell to third-party vendors!
line right in
spacer

News & Resources

line right in

Keep Up to Date with Vocxi Health and the latest scientific news

"Only a fraction of people at high risk for lung cancer are getting screened for the disease even though it kills more in the United States than breast, colorectal and prostate cancers combined."
"Minnesota is now eligible to compete for millions in federal dollars after being designated a tech hub by the U.S. Department of Commerce."
"The Biden administration designated 31 technology hubs touching 32 states and Puerto Rico to help spur innovation and create jobs in the industries that are concentrated in these areas."
spacer

A Breath-through Solution

line right in

Learn how and why Vocxi Health is transforming the patient journey through early disease detection!

Vocxi About Strategic Partners icons light blueArtboard 10

Why
MyBreathPrint

Learn more about why our team of scientists, medical-device and diagnostic leaders developed MyBreathPrint.

Vocxi About Strategic Partners icons light blueArtboard 9

What are
Vocs?

Volatile Organic Compounds are gaseous molecules that can originate from within the body or externally.